Full-Time

Lead Clinical Research Associate

PSI CRO

PSI CRO

1,001-5,000 employees

Global CRO delivering on-time patient enrollment

Compensation Overview

CA$124k - CA$153k/yr

Toronto, ON, Canada

Remote

Remote within Toronto, with travel up to 65% depending on project needs.

Category
Biology & Biotech (1)
Required Skills
Microsoft Office

Get referred to PSI CRO

See people who can refer or advise you

Requirements
  • Relevant educational background, such as a Doctor of Medicine, Master of Pharmacy, Registered Nurse, or college/university degree in Life Sciences, or an equivalent combination of education, training, and experience.
  • A minimum of 4 years of site monitoring experience with participation in global clinical projects as a Lead Monitor or equivalent qualification level.
  • Prior experience monitoring or managing sites and Clinical Research Associates, with knowledge of United States and Canadian regulatory guidelines and practices.
  • Experience with all types of monitoring visits in Phases I through III.
  • Full working proficiency in English.
  • Proficiency in Microsoft Office applications.
  • Ability to plan, multitask, and work in a dynamic team environment.
  • Excellent communication, collaboration, and problem-solving skills.
  • Ability to travel up to 65%, depending on project needs.
  • A valid driver's license, if applicable.
Responsibilities
  • Coordinate investigator and site feasibility and identification processes, as well as study startup.
  • Monitor project timelines and patient enrollment and implement corrective and preventive measures.
  • Review monitoring visit reports for all visit types and ensure reporting compliance of regional Monitors.
  • Manage Monitors in the query resolution process, including Central Monitoring observations.
  • Coordinate safety information flow and protocol or process deviation reporting.
  • Perform clinical supplies management with vendors at country and regional levels.
  • Ensure study-specific and corporate tracking systems are updated in a timely manner.
  • Act as the main communication line between the Monitor, Site Management Associate, Regional Project Lead, and Project Manager.
  • Coordinate planning of supervised monitoring visits and conduct the visits.
  • Manage the project team in site contracting and payments.
  • Lead country-level project team calls and provide status updates and reports to the Regional Lead or Project Manager.
  • Ensure ongoing evaluation of data integrity and compliance at country and regional levels.
  • Conduct site audit preparation visits, participate in site audits when applicable, and coordinate resolution of site audit findings at country and regional levels.
  • Oversee the project team in CAPA development and implementation.
  • Coordinate the project team in process deviation review, management, and reporting.
  • Conduct initial training and authorization monitoring visits for Monitors and mentor newly promoted Lead Clinical Research Associates.
  • Provide project-specific training and prepare training materials for the project team under the supervision of a Project Manager and Regional Project Lead.
  • Deliver training and presentations at Investigator Meetings.
  • Prepare, conduct, and report site selection, initiation, routine monitoring, and closeout visits.
  • Ensure subject recruitment targets and project timelines are properly defined, communicated, recorded, and met at site level.
  • Ensure accurate and timely information flow with trial sites regarding Adverse Events and protocol or process deviations.
  • Supervise source data verification and follow up on data queries at site level in the country or region, and review and manage study risks at site level.
  • Ensure proper handling, use, accountability, reconciliation, and return of Investigational Products and clinical study supplies at country or regional level.
  • Review essential study documents and supervise reconciliation of Investigator Site Files and Trial Master Files at site, country, and regional levels.
  • Ensure data integrity and compliance at site level.
  • Supervise Site Management Associates in the flow of documents and laboratory supplies between the site and the Central or Regional Laboratory or Central Reviewer.
  • Conduct project-specific training of site Investigators.
  • Support preparation of draft regulatory and ethics committee submission packages.
Desired Qualifications
  • Strong experience in oncology.
  • Experience in CAR-T therapy or other types of cell therapy, gene therapy, radiation therapy, radiopharmaceuticals, or nuclear medicine.
  • Strong experience in gastrointestinal conditions, including Crohn's disease, ulcerative colitis, and irritable bowel syndrome.

PSI CRO is a global contract research organization that handles clinical trials for multiple therapeutic areas, with a focus on enrolling patients on schedule and delivering studies on time. Its services span feasibility assessments, trial planning, site selection, patient recruitment, and multi-continent trial execution across 50+ countries, backed by medical doctor resources dedicated to accurate timeline predictions. Unlike many CROs, PSI emphasizes predictable enrollment and on-time project delivery, aiming for high client satisfaction and repeat business through a pragmatic, no-nonsense approach. The company’s goal is to be regarded as the best CRO in the world by both clients and employees, achieved through reliable timelines, strong execution, and low staff turnover.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Switzerland

Founded

1995

Get referred to PSI CRO

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Toronto expansion in January 2026 deepens PSI's North American delivery capacity.
  • Beijing's April 2026 launch improves access to Chinese regulators and investigator networks.
  • SYNETIC reduces non-enrolling site waste, saving studies millions in recruitment costs.

What critics are saying

  • IQVIA, ICON, and Parexel can copy PSI's AI site-selection advantage quickly.
  • Beijing and Toronto offices raise fixed costs if sponsor demand softens in 2026.
  • A major sponsor loss would crush utilization and threaten PSI's global CRO model.

What makes PSI CRO unique

  • PSI CRO opened Beijing in April 2026 to stay close to Chinese regulators.
  • PSI CRO operates a 58-country platform with 3,200-plus employees worldwide.
  • SYNETIC cuts site identification from six weeks to minutes with explainable AI.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Paid Vacation

Flexible Work Hours

Hybrid Work Options

Remote Work Options

Wellness Program

Mental Health Support

Conference Attendance Budget

Professional Development Budget

Company News

PSI CRO
Apr 28th, 2026
From Shanghai to Beijing: PSI CRO expands its footprint in China with a new Beijing office.

From Shanghai to Beijing: PSI CRO expands its footprint in China with a new Beijing office. Beijing, China - April 28, 2026 - PSI CRO, a Swiss-based global full-service contract research organization, today announced the opening of its second office in China, located in China World Tower B in Beijing's Chaoyang District. In 2019, PSI established its first China office in Shanghai, where the local team has steadily grown while supporting sponsors across the region. By adding a Beijing location, PSI brings its team closer to key drug regulatory authorities and leading research institutions. China is playing an increasingly important role in global clinical development, creating a growing need for strong local operational and regulatory support. PSI's presence in Beijing helps meet that need, combining local expertise with coordinated global teams to support clear decision-making and predictable, on-time delivery for sponsors. For PSI, the Beijing office represents a targeted investment to support clients where it matters most - close to regulators, close to investigator sites, and close to strategic partners.

PR Newswire
Mar 19th, 2026
PSI cuts clinical trial site selection from 6 weeks to minutes with AI agent on Arango platform

PSI CRO, a global clinical research organisation, has reduced clinical trial site identification from up to six weeks to minutes using SYNETIC, an AI knowledge engine powered by the Arango Contextual Data Platform. The system helps identify higher-performing trial sites and minimise costly non-enrolling institutions, which account for 30-40% of trial sites. Clinical trials can cost over $160 per minute operationally, and activating a trial site costs $30,000 or more. With 15% of sites never enrolling a single patient, failed recruitment can cost millions per study. SYNETIC unifies fragmented clinical research data into a single contextual layer, preserving relationships across investigators, institutions, protocols and historical outcomes. The platform provides explainable AI recommendations, including rationale, supporting evidence and confidence levels, enabling data-driven site selection in minutes rather than weeks.

PharmiWeb
Jan 7th, 2026
PSI CRO Strengthens Canadian Presence with New Toronto Office and Leadership Role

PSI CRO strengthens Canadian presence with new Toronto office and leadership role. PSI CRO has broadened its footprint in Canada by opening a new office in the Toronto area and naming an experienced industry leader to guide its operations there. The office, located in Mississauga, Ontario, builds on the company's established Canadian presence and commitment to clinical research excellence. PSI CRO has been active in Canada for over a decade, supporting complex clinical trials with a focus on dependable delivery and strong relationships with research sites. As part of this expansion, David Allen, MBA, has been appointed as Country Manager for Canada. Allen brings more than 30 years of experience in clinical research from both sponsor and CRO environments. In his new role, he will lead efforts to enhance the company's operational capabilities in the local market and ensure alignment with PSI's global standards for on-time trial execution. PSI's continued growth in North America reflects broader trends of increasing trial activity in the region, particularly for pivotal phase II and phase III studies where precision and efficiency are critical. The expanded Toronto operations aim to further support sponsors with rigorous trial planning and execution.

PSI CRO
Mar 13th, 2025
PSI CRO Appoints Sayaka Kaji as Country Manager Japan

TOKYO, 14 March 2025 - PSI CRO AG, a global Swiss-based clinical research organization (CRO), is pleased to announce the appointment of Sayaka Kaji as Country Manager for Japan.

PSI CRO
Sep 6th, 2023
PSI FAQs: How does PSI reduce CRA staff turnover on your project?

Psi CRO Ag launched a CRA Academy to provide to help its team members develop therapeutic expertise as well as soft skills to manage key relationships with sites.